Company Analysis

MiMedx Group, Inc (MDXG)

Nasdaq: MDXG · Surgical & Medical Instruments & Apparatus · Marietta, GA · filing with the SEC since 2007
Grade5.9
◀ Past 3.5● Present 7.3▶ Future 6.4

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

114 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to MiMedx Group, Inc’s names, not what it holds today.

Patents granted
114
114 utility, 1976 to Dec 31, 2025
Granted in 2025
3
Against 5 in 2024 and 7 in 2023
Applications published
121
2 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'10'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Medical technology16
Pharmaceuticals10
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
MiMedx Group, Inc. its own name
US, as the owner printed on each patent
114 granted
62 published
MiMedx Group, Inc. its own name
named as the applicant on its applications, in US
0 granted
59 published
Newest grantseach row opens the USPTO’s own copy
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Nov 20, 20252025/0352691ANIONIC POLYMER-IMPREGNATED MATRIX FOR THE LOCALIZATION OF PHMBMacromolecular chemistry, polymersMiMedx Group, Inc.
Feb 13, 20252025/0051723POURABLE PLACENTAL COLLAGEN MATRIX SHEETBiotechnologyMiMedx Group, Inc.
Dec 28, 20232023/0414670PLACENTAL TISSUE GRAFTS AND IMPROVED METHODS OF PREPARING AND USING THE SAMEPharmaceuticalsMiMedx Group, Inc.
Nov 2, 20232023/0347015LYOPHILIZED PERFORATED PLACENTAL MEMBRANE TISSUE GRAFTSMedical technologyMiMedx Group, Inc.
Jun 29, 20232023/0201419PLACENTAL TISSUE GRAFTS AND IMPROVED METHODS OF PREPARING AND USING THE SAMEMedical technologyMiMedx Group, Inc.
May 5, 20222022/0133955MESHED PLACENTAL MEMBRANE TISSUE GRAFTSMedical technologyMiMedx Group, Inc.
Apr 28, 20222022/0125855MICRONIZED PLACENTAL TISSUE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAMEMedical technologyMiMedx Group, Inc.
Apr 7, 20222022/0105138MICRONIZED PLACENTAL TISSUE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAMEMedical technologyMiMedx Group, Inc. · patent 11,931,384 granted from it
Dec 23, 20212021/0393852MESHED UMBILICAL CORD TISSUE GRAFTSMedical technologyMiMedx Group, Inc.
Sep 16, 20212021/0283190COMPOSITIONS AND METHODS OF TREATMENT WITH AMNIOTIC FLUIDPharmaceuticalsMiMedx Group, Inc. · patent 11,865,142 granted from it
What it applied for, 2024 to 2025: Biotechnology 1 · Macromolecular chemistry, polymers 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton MDXG · research, not advice